Molecular mechanisms of prothrombotic risk due to genetic variations in platelet genes: Enhanced outside-in signaling through the Pro33 variant of integrin β3

Experimental Biology and Medicine

Volumn 231, Issue 5, 2006, Pages 505-513

  Vijayan, K Vinod ^a   Bray, Paul F ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adhesion; Aggregation; Genes; Integrin; Platelets; Polymorphism; Signaling; Thrombosis

Indexed keywords

BETA3 INTEGRIN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IIB; PROLINE;

ANIMAL; CHEMISTRY; GENETIC POLYMORPHISM; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOSIS;

ANIMALS; BLOOD PLATELETS; HUMANS; INTEGRIN BETA3; PHENOTYPE; PLATELET MEMBRANE GLYCOPROTEIN IIB; PLATELET MEMBRANE GLYCOPROTEINS; POLYMORPHISM, GENETIC; PROLINE; RISK FACTORS; SIGNAL TRANSDUCTION; THROMBOSIS;

EID: 33744976086     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020623100504     Document Type: Short Survey

References (71)

1. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330:1041-1046, 1994.
2. Berg K. The genetics of the hyperlipidemias and coronary artery disease. Prog Clin Biol Res 103 (Pt B):111-125, 1982.
3. Sorensen TI, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 318:727-732, 1988.
4. Sing CF, Haviland MB, Templeton AR, Zerba KE, Reilly SL. Biological complexity and strategies for finding DNA variations responsible for inter-individual variation in risk of a common chronic disease, coronary artery disease. Ann Med 24:539-547, 1992.
5. A polymorphisms display different sensitivities to agonists. Circulation 101:1013-1018, 2000.
6. 3 subunit (glycoprotein IIIa). Br J Haematol 110:911-918, 2000.
7. Yee DL, Bray PF. Clinical and functional consequences of platelet membrane glycoprotein polymorphisms. Semin Thromb Hemost 30: 591-600, 2004.
8. Kunicki TJ, Nugent DJ. The influence of platelet glycoprotein polymorphisms on receptor function and risk for thrombosis. Vox Sang 83(Suppl 1):85-90, 2002.
9. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22:231-238, 1999.
10. Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, Cooper R, Lipshutz R, Chakravarti A. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet 22:239-247, 1999.
11. 2-adrenergic receptor is associated with increased platelet aggregation, baroreceptor sensitivity, and salt excretion in normotensive humans. Am J Hypertens 8:863-869, 1995.
12. Jacquelin B, Tarantino MD, Kritzik M, Rozenshteyn D, Koziol JA, Nurden AT, Kunicki TJ. Allele-dependent transcriptional regulation of the human integrin a2 gene. Blood 97:1721-1726, 2001.
13. Fontana P, Dupont A, Gandrille S, Bachelot-Loza C, Reny JL, Aiach M, Gaussem P. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 108:989-995, 2003.
14. 2 gene. J Biol Chem 276:23518-23524, 2001.
15. Ulrichts H, Vanhoorelbeke K, Cauwenberghs S, Vauterin S, Kroll H, Santoso S, Deckmyn H. von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibα is influenced by the HPA-2 polymorphism. Arterioscler Thromb Vasc Biol 23:1302-1307, 2003.
16. Matsubara Y, Murata M, Hayashi T, Suzuki K, Okamura Y, Handa M, Ishihara H, Shibano T, Ikeda Y. Platelet glycoprotein Ibα polymorphisms affect the interaction with von Willebrand factor under flow conditions. Br J Haematol 128:533-539, 2005.
17. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88:83-87, 1999.
18. Shimizu M, Kanazawa K, Matsuda Y, Takai E, Iwai C, Miyamoto Y, Hashimoto M, Akita H, Yokoyama M. Serotonin-2A receptor gene polymorphisms are associated with serotonin-induced platelet aggregation. Thromb Res 112:137-142, 2003.
19. Joutsi-Korhonen L, Smethurst PA, Rankin A, Gray E, IJsseldijk M, Onley CM, Watkins NA, Williamson LM, Goodall AH, de Groot PG, Farndale RW, Ouwehand WH. The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression. Blood 101:4372-4379, 2003.
20. Zeng SM, Murray JC, Widness JA, Strauss RG, Yankowitz J. Association of single nucleotide polymorphisms in the thrombopoietin-receptor gene, but not the thrombopoietin gene, with differences in platelet count. Am J Hematol 77:12-21, 2004.
21. Afshar-Kharghan V, Li CQ, Khoshnevis-Asl M, López JA. Kozak sequence polymorphism of the glycoprotein (GP) Ibα gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex. Blood 94:186-191, 1999.
22. i coupling. J Biol Chem 275:38518-38523, 2000.
23. Dupont A, Fontana P, Bachelot-Loza C, Reny JL, Bieche I, Desvard F, Aiach M, Gaussem P. An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN. Blood 101:1833-1840, 2003.
24. 3 subunit 825T allele. FEBS Lett 484:199-201, 2000.
25. a and affects collagen-induced aggregation. Blood 94:4103-4111, 1999.
26. 2 gene coding sequence. Blood 89:1939-1943, 1997.
27. 1 density. Blood 92:2382-2388, 1998.
28. 2 gene in platelet GP Ia collagen receptor expression and function - effect in thromboembolic diseases. Thromb Haemost 81:951-956, 1999.
29. Corral J, Rivera J, Gonzalez-Conejero R, Vicente V. The number of platelet glycoprotein Ia molecules is associated with the genetically linked 807 C/T and HPA-5 polymorphisms. Transfusion 39:372-378, 1999.
30. Di Paola J, Jugessur A, Goldman T, Reiland J, Tallman D, Sayago C, Murray JC. Platelet glycoprotein Ibalpha and integrin alphabeta polymorphisms: gene frequencies and linkage disequilibrium in a population diversity panel. J Thromb Haemost 3:1511-1521, 2005.
31. Tax WJ, Willems HW, Reekers PP, Capel PJ, Koene RA. Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells. Nature 304:445-447, 1983.
32. Warmerdam PA, van de Winkel JG, Gosselin EJ, Capel PJ. Molecular basis for a polymorphism of human Fcγ receptor II (CD32). J Exp Med 172:19-25, 1990.
33. Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ. A single amino acid in the second Ig-like domain of the human Fcγ receptor II is critical for human IgG2 binding. J Immunol 147:1338-1343, 1991.
34. Chen J, Dong JF, Sun C, Bergeron A, McBride L, Pillai M, Barnard MR, Salmon J, Michelson AD, Bray PF. Platelet FcgammaRIIA His131Arg polymorphism and platelet function: antibodies to platelet-bound fibrinogen induce platelet activation. J Thromb Haemost 1:355-362, 2003.
35. Roberts IAG, Murray NA. Thrombocytopenia in the newborn. In: Michelson AD, Ed. Platelets. San Diego: Academic Press, pp635-658, 2002.
36. A2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 83:1778-1781, 1989.
37. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 334:1090-1094, 1996.
38. A1/PlA2 and coronary risk: a meta-analysis. Thromb Haemost 85:626-633, 2001.
39. Wu AH, Tsongalis GJ. Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases. Am J Cardiol 87:1361-1366, 2001.
40. Kunicki TJ. Biochemistry of platelet-associated isoantigens and alloantigens. In: Kunicki TJ, George JN, Eds. Platelet Immunobiology: Molecular and Clinical Aspects. Philadelphia: Lippincott, pp99-120, 1989.
41. D'Souza SE, Byers-Ward VJ, Gardiner EE, Wang H, Sung SS. Identification of an active sequence within the first immunoglobulin domain of intercellular cell adhesion molecule-1 (ICAM-1) that interacts with fibrinogen. J Biol Chem 271:24270-24277, 1996.
42. Charo IF, Nannizzi L, Phillips DR, Hsu MA, Scarborough RM. Inhibition of fibrinogen binding to GP IIb-IIIa by a GP IIIa peptide. J Biol Chem 266:1415-1421, 1991.
43. A1/A2 polymorphism of platelet glycoprotein IIIa. Br J Haematol 110:965-967, 2000.
44. 3 integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation 104:2666-2672, 2001.
45. A2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 19:1142-1147, 1999.
46. 3. J Biol Chem 278:3860-3867, 2003.
47. A2 polymorphism. Br J Haematol 99: 801-807, 1997.
48. A2, Zwb) positive platelets in patients with cardiovascular disease. Eur Heart J 20:742-747, 1999.
49. A2): no association with platelet fibrinogen binding. Br J Haematol 105:664-666, 1999.
50. Feng D, Lindpaintner K, Larson MG, O'Donnell CJ, Lipinska I, Sutherland PA, Mittleman M, Muller JE, D'Agostino RB, Levy D, Tofler GH. Platelet glycoprotein IIIa Pl(A) polymorphism, fibrinogen, and platelet aggregability: the Framingham Heart Study. Circulation 104:140-144, 2001.
51. 3- integrins in platelets. Blood 97:3093-3099, 2001.
52. 3 enhances outside-in signaling and adhesive functions. J Clin Invest 105:793-802, 2000.
53. 3 differentially modulates cellular migration on extracellular matrix proteins. Arterioscler Thromb Vasc Biol 22:1984-1989, 2002.
54. 3. FEBS Lett 540:41-46, 2003.
55. 3 by modulation of transmembrane helix associations. Science 300:795-798, 2003.
56. Xiao T, Takagi J, Coller BS, Wang JH, Springer TA. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 432:59-67, 2004.
57. Berndt MC, Mazurov AV, Vinogradov DV, Burns GF, Chesterman CN. Topographical association of the platelet Fc-receptor with the glycoprotein IIb-IIIa complex. Platelets 4:190-196, 1993.
58. 3 integrin through its extracellular domain. J Biol Chem 275:39867-39873, 2000.
59. Brown E, Hooper L, Ho T, Gresham H. Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins. J Cell Biol 111:2785-2794, 1990.
60. 3 conformational states. Eur J Biochem 263:104-111, 1999.
61. Shattil SJ, Newman PJ. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood 104:1606-1615, 2004.
62. 3 enhances outside-in signaling in human platelets by regulating the activation of serine/threonine phosphatases. J Biol Chem 280:21756-21762, 2005.
63. Zhu X, Assoian RK. Integrin-dependent activation of MAP kinase: a link to shape-dependent cell proliferation. Mol Biol Cell 6:273-282, 1995.
64. Lai CF, Chaudhary L, Fausto A, Halstead LR, Ory DS, Avioli LV, Cheng SL. Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 276:14443-14450, 2001.
65. Fincham VJ, James M, Frame MC, Winder SJ. Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src. EMBO J 19:2911-2923, 2000.
66. Stockton RA, Jacobson BS. Modulation of cell-substrate adhesion by arachidonic acid: lipoxygenase regulates cell spreading and ERK1/2-inducible cyclooxygenase regulates cell migration in NIH-3T3 fibroblasts. Mol Biol Cell 12:1937-1956, 2001.
67. Kamm KE, Stull JT. Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem 276:4527-4530, 2001.
68. Daniel JL, Molish IR, Rigmaiden M, Stewart G. Evidence for a role of myosin phosphorylation in the initiation of the platelet shape change response. J Biol Chem 259:9826-9831, 1984.
69. 3 signalling and platelet function. Nature 401:808-811, 1999.
70. Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res 74:49-139, 1998.
71. 2. J Biol Chem 276:6922-6929, 2001.